Equity benchmarks extended rally in late trade, with the Nifty reclaiming 9900 level.
The 30-share BSE Sensex was up 244.55 points or 0.77 percentat 31,955.54, and the 50-share NSE Nifty rose 73.95 points or 0.75 percent to 9,901.10.
Lupin and Sun Pharma shares gained 1.8 percent each intraday after receiving approval from the US health regulator for drugs.
Pharma major Lupin has received approval from US Food and Drug Administration for Armodafinil that is used to treat excessive sleeping disorder.
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
You may also like:
|Sensex turns sluggish, Nifty still holds 9300; ICICI falls ahead of Q4||Sensex consolidates ahead of FOMC meet outcome; RBL Bank most active|